Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial
- 1 October 2006
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (10), 3479-3484
- https://doi.org/10.1128/aac.00210-06
Abstract
The activities of tigecycline and comparators against isolates collected from 76 U.S. centers between January 2004 and September 2005 were assessed. Tigecycline MIC 90 s were ≤2 μg/ml for Klebsiella pneumoniae , Klebsiella oxytoca , Escherichia coli , Enterobacter aerogenes , Enterobacter cloacae , Serratia marcescens , Acinetobacter baumannii , Staphylococcus aureus , Enterococcus faecalis , Enterococcus faecium , and Streptococcus agalactiae .Keywords
This publication has 16 references indexed in Scilit:
- Clinical impact and pathogenicity of AcinetobacterClinical Microbiology & Infection, 2005
- Overview of Nosocomial Infections Caused by Gram-Negative BacilliClinical Infectious Diseases, 2005
- In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal InfectionsClinical Infectious Diseases, 2005
- The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial DataClinical Infectious Diseases, 2005
- BK Virus: Opportunity Makes a PathogenClinical Infectious Diseases, 2005
- Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unitDiagnostic Microbiology and Infectious Disease, 2005
- MRSA – what is it, and how do we deal with the problem?Emerging Therapeutic Targets, 2005
- In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)Journal of Antimicrobial Chemotherapy, 2005
- Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)Diagnostic Microbiology and Infectious Disease, 2004
- Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)International Journal of Antimicrobial Agents, 2004